As of April 2024 Galmed Pharmaceuticals has a market cap of $2.15 Million. This makes Galmed Pharmaceuticals the world's 8314th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $2.15 M | 18.01% |
2023 | $1.82 M | -85.53% |
2022 | $12.6 M | -72.4% |
2021 | $45.65 M | -31.12% |
2020 | $66.28 M | -45.75% |
2019 | $0.12 B | -14.89% |
2018 | $0.14 B | 14.35% |
2017 | $0.12 B | 194.4% |
2016 | $42.64 M | -49.52% |
2015 | $84.47 M | 31.21% |
2014 | $64.38 M |
On Apr 22nd, 2024 the market cap of Galmed Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Evoke Pharma
EVOK | $3.98 M | 85.20% | ๐บ๐ธ USA |
Endo International
ENDPQ | $0.14 M | -93.44% | ๐ฎ๐ช Ireland |
Aerie Pharmaceuticals AERI | $0.75 B | 34,928.19% | ๐บ๐ธ USA |
Catalent CTLT | $10.13 B | 470,955.59% | ๐บ๐ธ USA |